The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| RXST | -70.69% | N/A | N/A | -52% |
| S&P | +19.17% | +69.21% | +11.09% | +52% |
RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.
| Q4 2025 | YOY Change | |
|---|---|---|
| Revenue | $32.61M | -18.9% |
| Gross Profit | $25.26M | -12.2% |
| Gross Margin | 77.47% | 5.9% |
| Market Cap | $428.44M | -69.1% |
| Market Cap / Employee | $929.36K | 0.0% |
| Employees | 461 | -7.4% |
| Net Income | -$9,152.00K | -54.1% |
| EBITDA | -$10,486.00K | -29.4% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2025 | YOY Change | |
|---|---|---|
| Net Cash | $19.95M | 19.4% |
| Accounts Receivable | $23.38M | -22.2% |
| Inventory | 31.6 | 43.4% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $9.88M | -12.8% |
| Short Term Debt | $1.16M | 19.3% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -12.25% | -1.4% |
| Return On Invested Capital | -16.83% | -80.6% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$2,253.00K | 55.9% |
| Operating Free Cash Flow | -$1,116.00K | 73.8% |
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 3.63 | 1.89 | 1.32 | 1.55 | -68.93% |
| Price to Sales | 6.90 | 3.60 | 2.59 | 3.19 | -67.82% |
| Price to Tangible Book Value | 3.63 | 1.89 | 1.32 | 1.55 | -68.93% |
| Enterprise Value to EBITDA | -81.46 | -23.75 | -13.45 | -20.21 | -85.91% |
| Return on Equity | -12.0% | -11.7% | -12.9% | -14.0% | 12.47% |
| Total Debt | $12.04M | $11.72M | $11.57M | $11.04M | -10.21% |
No podcast episodes available.
RXST earnings call for the period ending June 30, 2022.
RXST earnings call for the period ending March 31, 2022.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
